← Leaderboards
Riaz Gillani
Dana-Farber Cancer Inst
$579,581
Attributed
$579,581
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $208.3K · FY2023–25$250K$187.5K$125K$62.5K$0
'23
'24
'25
Funding mix
By agency
NIH$579,581 · 1
By mechanism
K08$579,581 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Alan David D'andrea$28,094,196
- Irene M. Ghobrial$24,445,801
- Rameen Beroukhim$9,639,646
- Brian Matthew Wolpin$8,665,523
- Robert Coleman Lindsley$5,306,772
Others in their field
Other Rising Stars on “Biological”
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Mari Ostendorf · University Of Washington$51,931,230
- Sabrina Paganoni · Massachusetts General Hospital$36,168,406
- Suma Babu · Massachusetts General Hospital$36,168,406
- Lauren Miller · Technical Resources International, Inc.$31,120,905
Research focus
BiologicalBiological FactorsBiological MarkersBiologyBone TissueCancer PredispositionCell LineCellsChildChildhood SarcomaClinically RelevantClinical TrialsCohortCombined Modality TherapyComplexComputational BiologyData SetDna DamageDna RepairEvaluationEwings SarcomaEwsr1 GeneFibroblastsAdolescent
Grant awards (3)
Dissecting the role of DNA damage repair deficiency in Ewing sarcoma pathogenesis for improved risk stratification and treatment$208,252
K08 · FY2025 · CA · contact PI
Dissecting the role of DNA damage repair deficiency in Ewing sarcoma pathogenesis for improved risk stratification and treatment$163,077
K08 · FY2024 · CA · contact PI
Dissecting the role of DNA damage repair deficiency in Ewing sarcoma pathogenesis for improved risk stratification and treatment$208,252
K08 · FY2023 · CA · contact PI